Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Insulin detemir
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Levemir FlexPen 100units/ml inj 3ml pre-filled pens
0601012X0BBABAB
|
Insulin Levemir (Novo-Nordisk) | Insulin detemir | Endocrine System | 86,733 |
|
Levemir Penfill 100units/ml inj 3ml cartridges
0601012X0BBAAAA
|
Insulin Levemir (Novo-Nordisk) | Insulin detemir | Endocrine System | 43,677 |
|
Insulin detemir 100units/ml inj 3ml pf dispos dev
0601012X0AAABAB
|
Insulin detemir | Insulin detemir | Endocrine System | 2,588 |
|
Insulin detemir 100units/ml inj 3ml cartridges
0601012X0AAAAAA
|
Insulin detemir | Insulin detemir | Endocrine System | 2,125 |
|
Levemir InnoLet 100units/ml inj 3ml pre-filled pens
0601012X0BBACAB
|
Insulin Levemir (Novo-Nordisk) | Insulin detemir | Endocrine System | 1,162 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.